Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1097)
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
43,149
Price
$15.36
Total Value
$662.62K
Shares Held After
851,746
% of Holdings
4.8%
ACHIEVE LIFE SCIENCES, INC. (ACHV)
Stewart Richard Alistair — Director
Shares
20,626
Price
$8.49
Total Value
$175.18K
Shares Held After
208,249
% of Holdings
9.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
4,884
Price
$14.00
Total Value
$68.38K
Shares Held After
141,053
% of Holdings
3.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
23,584
Price
$14.00
Total Value
$330.18K
Shares Held After
681,197
% of Holdings
3.3%
Liquidia Corp (LQDA)
Rielly-Gauvin Katherine — Director
Shares
36,789
Price
$74.99
Total Value
$2.76M
Shares Held After
44,637
% of Holdings
45.2%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
260
Price
$27.00
Total Value
$7.02K
Shares Held After
35,635
% of Holdings
0.7%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
31,487
Price
$12.63
Total Value
$397.68K
Shares Held After
195,444
% of Holdings
13.9%
Viridian Therapeutics, Inc.\DE (VRDN)
Tousignant Jennifer — Chief Legal Officer
Shares
10,000
Price
$24.50
Total Value
$245.00K
Shares Held After
0
% of Holdings
100.0%
Viridian Therapeutics, Inc.\DE (VRDN)
Tousignant Jennifer — Chief Legal Officer
Shares
4,212
Price
$24.50
Total Value
$103.19K
Shares Held After
0
% of Holdings
100.0%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
8,978
Price
$62.65
Total Value
$562.47K
Shares Held After
1,052,216
% of Holdings
0.8%
MACROGENICS INC (MGNX)
Peters Jeffrey Stuart — Senior VP, GC, and Secretary
Shares
31,105
Price
$4.15
Total Value
$129.09K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
57,476
Price
$0.35
Total Value
$20.12K
Shares Held After
7,856,650
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
409
Price
$0.35
Total Value
$143.15
Shares Held After
55,254
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
10,255
Price
$0.35
Total Value
$3.59K
Shares Held After
1,401,719
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
57,476
Price
$0.35
Total Value
$20.12K
Shares Held After
7,856,650
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
409
Price
$0.35
Total Value
$143.15
Shares Held After
55,254
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
10,255
Price
$0.35
Total Value
$3.59K
Shares Held After
1,401,719
% of Holdings
0.7%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,801
Price
$125.56
Total Value
$1.36M
Shares Held After
183,200
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$535.22
Total Value
$42.82K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$532.63
Total Value
$106.53K
Shares Held After
324,523
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$531.62
Total Value
$42.53K
Shares Held After
324,723
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
201
Price
$531.01
Total Value
$106.73K
Shares Held After
324,803
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
659
Price
$529.56
Total Value
$348.98K
Shares Held After
325,004
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,200
Price
$528.59
Total Value
$634.30K
Shares Held After
325,663
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,135
Price
$527.58
Total Value
$1.13M
Shares Held After
326,863
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,105
Price
$526.76
Total Value
$1.11M
Shares Held After
328,998
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
895
Price
$525.60
Total Value
$470.41K
Shares Held After
331,103
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$524.51
Total Value
$231.31K
Shares Held After
331,998
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,264
Price
$523.65
Total Value
$661.89K
Shares Held After
332,439
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$522.49
Total Value
$125.40K
Shares Held After
333,703
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
404
Price
$49.90
Total Value
$20.16K
Shares Held After
246,022
% of Holdings
0.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
302
Price
$156.77
Total Value
$47.34K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
102
Price
$155.59
Total Value
$15.87K
Shares Held After
302
% of Holdings
25.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
400
Price
$153.00
Total Value
$61.20K
Shares Held After
404
% of Holdings
49.8%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,998
Price
$151.80
Total Value
$303.29K
Shares Held After
804
% of Holdings
71.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,500
Price
$151.39
Total Value
$227.08K
Shares Held After
2,802
% of Holdings
34.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
100
Price
$85.65
Total Value
$8.56K
Shares Held After
505,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,800
Price
$84.69
Total Value
$152.44K
Shares Held After
505,786
% of Holdings
0.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,100
Price
$83.86
Total Value
$679.26K
Shares Held After
507,586
% of Holdings
1.6%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,700
Price
$0.35
Total Value
$945.00
Shares Held After
36,899
% of Holdings
7.3%
Phio Pharmaceuticals Corp. (PHIO)
Plott Ronald Todd — Director
Shares
15,000
Price
$1.14
Total Value
$17.10K
Shares Held After
15,000
% of Holdings
100.0%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
50,000
Price
$74.06
Total Value
$3.70M
Shares Held After
142,265
% of Holdings
26.0%
Camp4 Therapeutics Corp (CAMP)
Tardiff Daniel — Chief Scientific Officer
Shares
1,738
Price
$4.76
Total Value
$8.27K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,200
Price
$107.77
Total Value
$344.85K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,600
Price
$107.22
Total Value
$1.03M
Shares Held After
770,980
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,200
Price
$106.36
Total Value
$765.78K
Shares Held After
780,580
% of Holdings
0.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
30,918
Price
$1.65
Total Value
$50.89K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
31,000
Price
$1.65
Total Value
$51.03K
Shares Held After
48,750
% of Holdings
38.9%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,892
Price
$18.19
Total Value
$88.99K
Shares Held After
77,786
% of Holdings
5.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
2,778
Price
$117.55
Total Value
$326.55K
Shares Held After
0
% of Holdings
100.0%
Showing 601–650 of 1097 transactions (page 13 of 22)